P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer

Xin Wang, Mingyue Ma, Mingyu Zhang, Han Lu, Ying Liu, Yang Zhou, Bing Han · 2026

Read P2RY6+ tumor-associated macrophages as a therapeutic target: suppressing tumor growth and enhancing chemosensitivity in triple-negative breast cancer by Xin Wang, Mingyue Ma, Mingyu Zhang, Han Lu, Ying Liu, Yang Zhou, Bing Han (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13473056.txt.

Description

Wang and co-authors fingered a receptor on tumor-associated macrophages, the immune cells that shield triple-negative breast cancer, as a drug target. Their 2026 study combined single-cell data, tissue arrays from 29 surgical patients, and mouse tumor models to trace how the UDP-sensing receptor P2RY6 steers macrophages into tumor-helping mode.

Activated P2RY6 pushed macrophages toward the M2-like state through a calcium signaling chain. It made them secrete S100A9, a protein that switches on NF-κB growth signaling in the cancer cells themselves. Tumors dense in P2RY6-positive macrophages carried a poor prognosis for patients. Blocking the receptor, genetically or with drugs, or neutralizing S100A9 slowed tumor growth in mice and restored sensitivity to chemotherapy, the team reports.

Catalog record

CREATORXin Wang, Mingyue Ma, Mingyu Zhang, Han Lu, Ying Liu, Yang Zhou, Bing Han
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE59 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13473056

Browse the full library · About the Tower of Babel